- Home
- CCRD vs FENC Comparison
CCRD vs FENC Comparison
Compare CCRD & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCRD
- FENC
- Stock Information
- Founded
- CCRD 1973
- FENC 1996
- Country
- CCRD United States
- FENC United States
- Employees
- CCRD N/A
- FENC N/A
- Industry
- CCRD
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CCRD
- FENC Health Care
- Exchange
- CCRD Nasdaq
- FENC Nasdaq
- Market Cap
- CCRD 215.8M
- FENC 225.4M
- IPO Year
- CCRD N/A
- FENC 2001
- Fundamental
- Price
- CCRD $27.10
- FENC $8.76
- Analyst Decision
- CCRD Hold
- FENC Strong Buy
- Analyst Count
- CCRD 1
- FENC 2
- Target Price
- CCRD $21.00
- FENC $13.50
- AVG Volume (30 Days)
- CCRD 77.9K
- FENC 58.2K
- Earning Date
- CCRD 10-30-2025
- FENC 11-06-2025
- Dividend Yield
- CCRD N/A
- FENC N/A
- EPS Growth
- CCRD 432.93
- FENC N/A
- EPS
- CCRD 0.99
- FENC N/A
- Revenue
- CCRD $64,808,000.00
- FENC $33,302,000.00
- Revenue This Year
- CCRD $17.35
- FENC $0.96
- Revenue Next Year
- CCRD N/A
- FENC $51.71
- P/E Ratio
- CCRD $27.30
- FENC N/A
- Revenue Growth
- CCRD 23.61
- FENC N/A
- 52 Week Low
- CCRD $12.12
- FENC $3.96
- 52 Week High
- CCRD $31.99
- FENC $9.42
- Technical
- Relative Strength Index (RSI)
- CCRD 47.17
- FENC 50.16
- Support Level
- CCRD $26.65
- FENC $8.96
- Resistance Level
- CCRD $27.73
- FENC $9.23
- Average True Range (ATR)
- CCRD 0.56
- FENC 0.27
- MACD
- CCRD -0.02
- FENC 0.00
- Stochastic Oscillator
- CCRD 31.03
- FENC 34.57
About CCRD CoreCard Corporation
CoreCard Corp is engaged in the business of providing technology solutions and processing services to the financial technology and services market. It designs, develops and markets a comprehensive suite of software solutions to program managers, accounts receivable businesses, financial institutions, retailers and processors to manage their credit and debit cards, prepaid cards, private label cards, fleet cards, buy now pay later programs, loyalty programs and accounts receivable and loan transactions. The CoreCard software platform and modules include CoreENGINE, CoreISSUE, CoreFRAUD, CoreCOLLECT, CoreAPP, CoreMONEY and CoreACQUIRE. Its customers are located in the U.S, European Union and the Middle East of which key revenue is derived from the U.S.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.